Diagnosis and causal treatment of sepsis;Diagnose und kausale therapie der sepsis

Internist

Volumn 50, Issue 7, 2009, Pages 810-816

  Brunkhorst, F M ^a   Reinhart, K ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Antibiotic resistance; Antibiotic therapy; Diagnostics; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; EARLY DIAGNOSIS; GRAM NEGATIVE INFECTION; HUMAN; MORBIDITY; MORTALITY; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SEPTIC SHOCK;

ANTI-BACTERIAL AGENTS; HUMANS; SEPSIS;

EID: 69049097024     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-008-2287-5     Document Type: Review

References (24)

1. Baddour 2004 Am J Respir Crit Care Med 170 440
2. Barie 2004 Am J Surg 188 212
3. Centers for Disease Control and Prevention http://www.cdc.gov/ncidod/hip/ NNIS/members/2001NNIS-report.pdf
4. Chastre 2003 JAMA 290 2588
5. Christ-Crain 2004 Lancet 363 600
6. ClinicalTrials.gov (2009) Comparison of two antibiotic regimen (meropenem versus meropenem+moxifloxacin) in the treatment of severe sepsis and septic shock (MaxSep). http://clinicaltrials.gov/ct2/show/study/NCT00534287?view= results
7. Engel 2007 Intensive Care Med 33 606
8. European Antimicrobial Resistance Surveillance System (2008) EARSS Annual Report 2007. http://www.rivm.nl/earss/Images/EARSS%202007-FINAL-tcm61-55933.pdf
9. Harbarth 2001 Am J Respir Crit Care Med 164 396
10. Heyland 2006 N Engl J Med 355 2619
11. Kujath 2007 Zentralbl Chir 132 427
12. Kumar 2006 Crit Care Med 34 1589
13. Levy 2003 Intensive Care Med 29 530
14. Mandell 2003 Clin Infect Dis 37 1405
15. Meisner M (2000) Procalcitonin. A new, innovative infection parameter, 3rd ed. Thieme, Stuttgart
16. Micek 2005 Antimicrob Agents Chemother 49 1306
17. Nobre 2008 Am J Respir Crit Care Med 177 498
18. Paul 2004 BMJ 328 668
19. Rangel-Frausto 1995 JAMA 273 117
20. Reimer 1997 Clin Microbiol Rev 10 444
21. Reinhart K, Brunkhorst FM, Bone HG et al. (2006) Diagnose und Therapie der Sepsis: S2-Leitlinien der Deutschen Sepsisgesellschaft e.V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI). Internist (Berl) 47: 356-373
22. Safdar 2004 Lancet Infect Dis 4 519
23. Schrenzel 2007 Int J Antimicrob Agents S2
24. Trouillet 1998 Am J Respir Crit Care Med 157 531